Accessibility Menu
 
Ocugen logo

Ocugen

(NASDAQ) OCGN

Current Price$2.03
Market Cap$668.91M
Since IPO (2019)-28%
5 Year-77%
1 Year+254%
1 Month+38%

Ocugen Financials at a Glance

Market Cap

$668.91M

Revenue (TTM)

$4.41M

Net Income (TTM)

$67.85M

EPS (TTM)

$-0.23

P/E Ratio

-9.04

Dividend

$0.00

Beta (Volatility)

1.98 (High)

Price

$2.03

Volume

200,427

Open

$2.24

Previous Close

$2.03

Daily Range

$2.02 - $2.27

52-Week Range

$0.57 - $2.73

OCGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ocugen

Industry

Biotechnology

Employees

116

CEO

Shankar Musunuri, PhD, MBA

Headquarters

Malvern, PA 19355, US

OCGN Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-14%

Net Income Margin

-15%

Return on Equity

-777%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

-11.06%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$668.91M

Shares Outstanding

327.90M

Volume

200.43K

Short Interest

0.00%

Avg. Volume

7.19M

Financials (TTM)

Gross Profit

$2.02M

Operating Income

$62.92M

EBITDA

$60.53M

Operating Cash Flow

$56.96M

Capital Expenditure

$185.00K

Free Cash Flow

$57.15M

Cash & ST Invst.

$18.57M

Total Debt

$33.14M

Ocugen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$193.00K

-125.3%

Gross Profit

$193.00K

-125.3%

Gross Margin

100.00%

N/A

Market Cap

$668.91M

N/A

Market Cap/Employee

$7.04M

N/A

Employees

95

N/A

Net Income

$17.71M

-27.6%

EBITDA

$16.28M

-22.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$14.57M

-156.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$31.04M

+1.2%

Short Term Debt

$2.11M

+14.3%

Return on Assets

-1.53%

N/A

Return on Invested Capital

-2.96%

N/A

Free Cash Flow

$14.00M

-34.9%

Operating Cash Flow

$13.96M

-34.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LXRXLexicon Pharmaceuticals, Inc.
$1.56-3.70%
CMPXCompass Therapeutics, Inc.
$5.15-4.45%
OMEROmeros Corporation
$11.00-1.08%
ADCTADC Therapeutics S.A.
$3.86-4.46%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
ANNAAleAnna
$7.07+0.87%

Questions About OCGN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.